Q2 2019 Biocept Inc Earnings Call
שיחת ועידה Biocept Inc
Biocept Inc Conference call will be held on 12/08/2019. During the earnings conference call's session Biocept Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Biocept Inc for this information
Schedule an online conference with QCONF conference service and get 5 free calls with online conferencing.
We are an early commercial-stage molecular oncology diagnostics company that develops and commercializes proprietary circulating tumor cell, or CTC, and circulating tumor DNA, or ctDNA, assays utilizing a standard blood sample, or "liquid biopsy." Our current breast, lung and gastric cancer assays provide, and our planned future assays would provide, information to oncologists and other physicians that enable them to select appropriate personalized treatment for their patients based on better, timelier and more-detailed data on the characteristics of their patients' tumors. Our current assays and our planned future assays focus on all the key solid tumor indications utilizing our Target-SelectorTM offering for the biomarker analysis of CTCs and ctDNA from a standard blood sample.קרא עוד שיחת ועידה